Page last updated: 2024-10-28

glipizide and Weight Loss

glipizide has been researched along with Weight Loss in 2 studies

Glipizide: An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.
glipizide : An N-sulfonylurea that is glyburide in which the (5-chloro-2-methoxybenzoyl group is replaced by a (5-methylpyrazin-2-yl)carbonyl group. An oral hypoglycemic agent, it is used in the treatment of type 2 diabetes mellitus.

Weight Loss: Decrease in existing BODY WEIGHT.

Research Excerpts

ExcerptRelevanceReference
"The addition of sibutramine to oral hypoglycemic therapy resulted in significant weight loss and improvement in metabolic parameters in this patient group."5.09Effects of sibutramine in obese female subjects with type 2 diabetes and poor blood glucose control. ( Ertorer, EM; Gokcel, A; Guvener, N; Karakose, H; Tanaci, N; Tutuncu, NB, 2001)
"Weight loss was maintained throughout the study, which lasted 24 weeks."1.28Relationships between the amount of weight loss and post-heparin lipoprotein lipase activity in patients with type II diabetes. ( Darga, LL; Holden, JH; Jen, KL; Kasim, SE; Khilnani, S; Lucas, CP; Patton, S, 1991)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gokcel, A1
Karakose, H1
Ertorer, EM1
Tanaci, N1
Tutuncu, NB1
Guvener, N1
Kasim, SE1
Darga, LL1
Holden, JH1
Khilnani, S1
Patton, S1
Jen, KL1
Lucas, CP1

Trials

1 trial available for glipizide and Weight Loss

ArticleYear
Effects of sibutramine in obese female subjects with type 2 diabetes and poor blood glucose control.
    Diabetes care, 2001, Volume: 24, Issue:11

    Topics: Appetite Depressants; Blood Glucose; Cholesterol; Cyclobutanes; Diabetes Mellitus; Double-Blind Meth

2001

Other Studies

1 other study available for glipizide and Weight Loss

ArticleYear
Relationships between the amount of weight loss and post-heparin lipoprotein lipase activity in patients with type II diabetes.
    International journal of obesity, 1991, Volume: 15, Issue:12

    Topics: Apolipoprotein A-I; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mel

1991